Stratagene and Harvard Bio Only Gainers as BCW Index Falls
Shares of Stratagene jumped 10 percent and shares of Harvard Bioscience improved a fraction as the BioCommerce Week Index returned after the holiday break.
Stratagene closed at the end of trading Tuesday at $7.37, up over the previous closing price of $6.70 on Dec. 21 before the holiday break, while Harvard Bio improved to $4.37 from the previous close of $4.35.
Bruker BioSciences dropped 11 percent during the period, closing Tuesday at $3.80, down from $4.29, as a total of 13 companies in the index saw share prices fall.
Thermo Electron, which filed a patent-infringement lawsuit against Applera in December, followed Bruker, losing 4 percent, closing at $29.31, down from $30.58 (see story, page 1).
Overall, the index fell 2 percent as the overall market indices all dropped on Tuesday reacting to news that the Federal Reserve expressed concern in its December meeting that interest rates were too low to contain inflation. The Nasdaq index closed with its largest one-day percentage decline in five months. Since the last day of trading in 2004, the Dow Jones index has fallen 1.4 percent while the S&P 500 declined nearly 2 percent in the same period. The Amex biotechnology index dropped nearly 4 percent in that same period while the Amex pharmaceutical index fell 2 percent.
Following is a preliminary schedule of quarterly financial reporting dates for the BCW Index companies:
- Agilent: No date set
- Applied Biosystems: No date set
- Becton Dickinson: Jan. 24
- Beckman Coulter: Jan. 28
- Bio-Rad: Feb. 17
- Bruker BioScience: No date set
- General Electric: Jan. 21
- Harvard Bioscience: No date set
- Invitrogen: No date set
- Molecular Devices: Jan. 31
- Sigma-Aldrich: Feb. 8
- Stratagene: Feb. 7
- Thermo: Feb. 2
- Waters: No date set